A test of vitamin D benefits on respiratory health mediated through inflammatory markers

Chronic Respiratory Disease

Volumn 12, Issue 1, 2015, Pages 24-30

  Hendryx, Michael ^a   Luo, Juhua ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

COPD; inflammation; lung disease; NHANES; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; VITAMIN D; 25-HYDROXYVITAMIN D;

ADULT; ARTICLE; BASOPHIL; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EOSINOPHIL; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LEUKOCYTE; LUNG DISEASE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; SELF REPORT; SMOKING; SYMPTOM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ABNORMAL RESPIRATORY SOUND; AGED; ANALOGS AND DERIVATIVES; BLOOD; COUGHING; CROSS-SECTIONAL STUDY; CYTOLOGY; IMMUNOLOGY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MIDDLE AGED; MONOCYTE; NUTRITION; YOUNG ADULT;

ADULT; AGED; ALKALINE PHOSPHATASE; BASOPHILS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COUGH; CROSS-SECTIONAL STUDIES; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; NUTRITION SURVEYS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SOUNDS; SMOKING; VITAMIN D; YOUNG ADULT;

EID: 84921468929     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972314556086     Document Type: Article

References (34)

1. Wiseman H.. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett. 1993 ; 326 ((1-3)). 285-288
2. Krishnan AV, Feldman D. Mechanisms of the anticancer and anti-inflammatory actions of vitamin D. Ann Rev Pharmacol Toxicol. 2011 ; 51: 311-336
3. Dong JY, Zhang WG, Chen JJ, et al. Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients. 2013 ; 5 ((9)). 3551-3562
4. Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circul Res. 2014 ; 114 ((2)). 379-393
5. Lips P. Vitamin D physiology. Progress Biophys Molec Biol. 2006 ; 92 ((1)). 4-8
6. Bozzetto S, Carraro S, Giordano G, et al. Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy. 2012 ; 67 ((1)). 10-17
7. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005 ; 128 ((6)). 3792-3798
8. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010 ; 65 ((3)). 215-220
9. Hirani V. Associations between vitamin D and self-reported respiratory disease in older people from a nationally representative population survey. J Am Geriatr Soc. 2013 ; 61 ((6)). 969-973
10. Herr C, Greulich T, Koczulla RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011 ; 12: 31
11. Laaksi I, Ruohola JP, Mattila V. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis. 2010 ; 202 ((5)). 809-814
12. Hughes DA, Norton R. Vitamin D and respiratory health. Clin Exper Immunol. 2009 ; 158 ((1)). 20-25
13. Pfeffer PE, Hawrylowics CM. Vitamin D and lung disease. Thorax. 2012 ; 67: 1018-1020
14. Grossmann RE, Zughaier SM, Liu S, et al. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutrit. 2012 ; 66 ((9)). 1072-1074
15. Shab-Bidar S, Neyestani TR, Djazayery A, et al. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes/Metab Res Rev. 2012 ; 28 ((5)). 424-430
16. Neyestani TR, Nikooyeh B, Alavi-Majd H, et al. Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J Clin Endocrinol Metab. 2012 ; 97 (6). 2005-2011
17. Capelli A, Lusuardi M, Cerutti CG, et al. Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders. Am J Respir Crit Care Med. 1997 ; 155 ((1)). 249-253
18. Pearce MS, Hancox RJ, Parker L, et al. Lung function and plasma fibrinogen concentrations in the Newcastle Thousand Families birth cohort between age 49 and 51 years. Respirol. 2014 ; 19 ((1)). 53-57
19. Sampson AP. The role of eosinophils and neutrophils in inflammation. Clin Exper Allergy: J Brit Soc Allergy Clin Immunol. 2000 ; 30 ((Suppl 1)). 22-27
20. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med. 2003 ; 114 ((9)). 758-762
21. Chandler PD, Scott JB, Drake BF, et al. Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial. Canc Preven Res. 2014 ; 7 ((2)). 218-225
22. Arnson Y, Itzhaky D, Mosseri M, et al. Vitamin D inflammatory cytokines and coronary events: a comprehensive review. Clin Rev Allergy Immunol. 2013 ; 45 ((2)). 236-247
23. Afzal S, Lange P, Bojesen SE, et al. Authors' response to Young and Hopkins: vitamin D and lung function. Thorax. 2014 ; 69: 24-31
24. Young RP, Hopkins RJ. Vitamin D and lung function. Thorax. 2014 ; 69: 769-770
25. CDC. National Health and Nutrition Examination Survey: Questionnaires, Datasets and Related Documentation. US Department of Health and Human Services, Centers for Disease Control and Prevention, 2014. Available at: http://www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm(accessed 20 February 2014).
26. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. J Personal Soc Psychol. 1986 ; 51: 1173-1182
27. Johnson CL, Paulose-Ram R, Ogden CL, et al
28. Su F, Brands R, Wang Z, et al. Beneficial effects of alkaline phosphatase in septic shock. Crit Care Med. 2006 ; 34 ((8)). 2182-2187
29. Pickkers P, Heemskerk S, Schouten J, et al. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Crit Care. 2012 ; 16 ((1)). R14
30. Huizinga R, Kreft KL, Onderwater S, et al. Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation. J Neuroinflamm. 2012 ; 9: 266
31. Jadhav AA, Jain A. Sputum adenosine deaminase and alkaline phosphatase activity in pulmonary tuberculosis. Arch Physiol Biochem. 2012 ; 118 ((1)). 6-9
32. Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunologic Res. 2004 ; 30 ((3)). 261-277
33. Hoffmann B, Moebus S, Dragano N, et al. Chronic residential exposure to particulate matter air pollution and systemic inflammatory markers. Environ Health Perspect. 2009 ; 117 ((8)). 1302-1308
34. Hertel S, Viehmann A, Moebus S, et al. Influence of short-term exposure to ultrafine and fine particles on systemic inflammation. Eur J Epidemiol. 2010 ; 25 ((8)). 581-592